Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001628280-25-005842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $26.54 | -78 | 156.6K | -0.0% | -$2,070 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | S | D | 78 | $26.54 | 156,567 | D | — | — |